Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation
Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, t...
Gespeichert in:
Veröffentlicht in: | The Journal of experimental medicine 2001-08, Vol.194 (4), p.551-556 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 556 |
---|---|
container_issue | 4 |
container_start_page | 551 |
container_title | The Journal of experimental medicine |
container_volume | 194 |
creator | Lukacs, N W Prosser, D M Wiekowski, M Lira, S A Cook, D N |
description | Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma. |
doi_str_mv | 10.1084/jem.194.4.551 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2193496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71118318</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</originalsourceid><addsrcrecordid>eNqFkU1rGzEQhkVpqF23x1zDnnpbR6MvS5dAME1aMAmE9CzW8siWs1rZ2t1A_31VYpL0VBgYGD28vOIh5BzoHKgWl3uMczBiLuZSwgcyBSlobSTXH8mUUsZqoHQxIZ_7fk8pCCHVJzIBkCAU0Cm5e8DjGDJG7IbKp1wNO6zcDmN6Ch1WGR0ehnJeLh9UFbqqaVvM2-Cqw9jG1DX5d7n6tomxGULqvpAz37Q9fj3tGfl18_1x-aNe3d_-XF6vaic0HeqNcgoVR-mNl2gkoJPIwTunvN4szJor7VEZZSRzlCohvGHCaeYk03yz5jNy9ZJ7GNcRN660z01rDznEUsmmJth_X7qws9v0bBkYLowqAd9OATkdR-wHG0PvsG2bDtPY2wUAaF7mfyBoxhk1poD1C-hy6vuM_rUNUPtXlS2qbFFlhS2qCn_x_gtv9MkN_wPOfpEG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18232099</pqid></control><display><type>article</type><title>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lukacs, N W ; Prosser, D M ; Wiekowski, M ; Lira, S A ; Cook, D N</creator><creatorcontrib>Lukacs, N W ; Prosser, D M ; Wiekowski, M ; Lira, S A ; Cook, D N</creatorcontrib><description>Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.194.4.551</identifier><identifier>PMID: 11514610</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Animals ; Asthma - immunology ; Asthma - metabolism ; Asthma - physiopathology ; Brief Definitive Report ; CCR6 protein ; Cytokines - metabolism ; Hypersensitivity - immunology ; Hypersensitivity - metabolism ; Hypersensitivity - physiopathology ; Immunoglobulin E - biosynthesis ; macrophage inflammatory protein 3^a ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Pneumonia - immunology ; Pneumonia - metabolism ; Pneumonia - physiopathology ; Receptors, CCR6 ; Receptors, Chemokine - genetics ; Receptors, Chemokine - metabolism ; Receptors, Chemokine - physiology ; Th2 Cells - immunology ; Th2 Cells - metabolism</subject><ispartof>The Journal of experimental medicine, 2001-08, Vol.194 (4), p.551-556</ispartof><rights>2001 The Rockefeller University Press 2001 The Rockefeller University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</citedby><cites>FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11514610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lukacs, N W</creatorcontrib><creatorcontrib>Prosser, D M</creatorcontrib><creatorcontrib>Wiekowski, M</creatorcontrib><creatorcontrib>Lira, S A</creatorcontrib><creatorcontrib>Cook, D N</creatorcontrib><title>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.</description><subject>Animals</subject><subject>Asthma - immunology</subject><subject>Asthma - metabolism</subject><subject>Asthma - physiopathology</subject><subject>Brief Definitive Report</subject><subject>CCR6 protein</subject><subject>Cytokines - metabolism</subject><subject>Hypersensitivity - immunology</subject><subject>Hypersensitivity - metabolism</subject><subject>Hypersensitivity - physiopathology</subject><subject>Immunoglobulin E - biosynthesis</subject><subject>macrophage inflammatory protein 3^a</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Pneumonia - immunology</subject><subject>Pneumonia - metabolism</subject><subject>Pneumonia - physiopathology</subject><subject>Receptors, CCR6</subject><subject>Receptors, Chemokine - genetics</subject><subject>Receptors, Chemokine - metabolism</subject><subject>Receptors, Chemokine - physiology</subject><subject>Th2 Cells - immunology</subject><subject>Th2 Cells - metabolism</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rGzEQhkVpqF23x1zDnnpbR6MvS5dAME1aMAmE9CzW8siWs1rZ2t1A_31VYpL0VBgYGD28vOIh5BzoHKgWl3uMczBiLuZSwgcyBSlobSTXH8mUUsZqoHQxIZ_7fk8pCCHVJzIBkCAU0Cm5e8DjGDJG7IbKp1wNO6zcDmN6Ch1WGR0ehnJeLh9UFbqqaVvM2-Cqw9jG1DX5d7n6tomxGULqvpAz37Q9fj3tGfl18_1x-aNe3d_-XF6vaic0HeqNcgoVR-mNl2gkoJPIwTunvN4szJor7VEZZSRzlCohvGHCaeYk03yz5jNy9ZJ7GNcRN660z01rDznEUsmmJth_X7qws9v0bBkYLowqAd9OATkdR-wHG0PvsG2bDtPY2wUAaF7mfyBoxhk1poD1C-hy6vuM_rUNUPtXlS2qbFFlhS2qCn_x_gtv9MkN_wPOfpEG</recordid><startdate>20010820</startdate><enddate>20010820</enddate><creator>Lukacs, N W</creator><creator>Prosser, D M</creator><creator>Wiekowski, M</creator><creator>Lira, S A</creator><creator>Cook, D N</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010820</creationdate><title>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</title><author>Lukacs, N W ; Prosser, D M ; Wiekowski, M ; Lira, S A ; Cook, D N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Asthma - immunology</topic><topic>Asthma - metabolism</topic><topic>Asthma - physiopathology</topic><topic>Brief Definitive Report</topic><topic>CCR6 protein</topic><topic>Cytokines - metabolism</topic><topic>Hypersensitivity - immunology</topic><topic>Hypersensitivity - metabolism</topic><topic>Hypersensitivity - physiopathology</topic><topic>Immunoglobulin E - biosynthesis</topic><topic>macrophage inflammatory protein 3^a</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Pneumonia - immunology</topic><topic>Pneumonia - metabolism</topic><topic>Pneumonia - physiopathology</topic><topic>Receptors, CCR6</topic><topic>Receptors, Chemokine - genetics</topic><topic>Receptors, Chemokine - metabolism</topic><topic>Receptors, Chemokine - physiology</topic><topic>Th2 Cells - immunology</topic><topic>Th2 Cells - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lukacs, N W</creatorcontrib><creatorcontrib>Prosser, D M</creatorcontrib><creatorcontrib>Wiekowski, M</creatorcontrib><creatorcontrib>Lira, S A</creatorcontrib><creatorcontrib>Cook, D N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lukacs, N W</au><au>Prosser, D M</au><au>Wiekowski, M</au><au>Lira, S A</au><au>Cook, D N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>2001-08-20</date><risdate>2001</risdate><volume>194</volume><issue>4</issue><spage>551</spage><epage>556</epage><pages>551-556</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>11514610</pmid><doi>10.1084/jem.194.4.551</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1007 |
ispartof | The Journal of experimental medicine, 2001-08, Vol.194 (4), p.551-556 |
issn | 0022-1007 1540-9538 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2193496 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Animals Asthma - immunology Asthma - metabolism Asthma - physiopathology Brief Definitive Report CCR6 protein Cytokines - metabolism Hypersensitivity - immunology Hypersensitivity - metabolism Hypersensitivity - physiopathology Immunoglobulin E - biosynthesis macrophage inflammatory protein 3^a Mice Mice, Inbred C57BL Mice, Knockout Pneumonia - immunology Pneumonia - metabolism Pneumonia - physiopathology Receptors, CCR6 Receptors, Chemokine - genetics Receptors, Chemokine - metabolism Receptors, Chemokine - physiology Th2 Cells - immunology Th2 Cells - metabolism |
title | Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T13%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Requirement%20for%20the%20chemokine%20receptor%20CCR6%20in%20allergic%20pulmonary%20inflammation&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Lukacs,%20N%20W&rft.date=2001-08-20&rft.volume=194&rft.issue=4&rft.spage=551&rft.epage=556&rft.pages=551-556&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.194.4.551&rft_dat=%3Cproquest_pubme%3E71118318%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18232099&rft_id=info:pmid/11514610&rfr_iscdi=true |